You are currently on the new version of our website. Access the old version .

684 Results Found

  • Review
  • Open Access
182 Citations
23,575 Views
93 Pages

Natural Products as Alternative Choices for P-Glycoprotein (P-gp) Inhibition

  • Saikat Dewanjee,
  • Tarun K. Dua,
  • Niloy Bhattacharjee,
  • Anup Das,
  • Moumita Gangopadhyay,
  • Ritu Khanra,
  • Swarnalata Joardar,
  • Muhammad Riaz,
  • Vincenzo De Feo and
  • Muhammad Zia-Ul-Haq

Multidrug resistance (MDR) is regarded as one of the bottlenecks of successful clinical treatment for numerous chemotherapeutic agents. Multiple key regulators are alleged to be responsible for MDR and making the treatment regimens ineffective. In th...

  • Article
  • Open Access
4 Citations
4,184 Views
11 Pages

10 January 2018

GP-1 is a novel glycoprotein produced by Streptomyces kanasenisi ZX01 that was isolated from soil near Kanas Lake with significant bioactivity against tobacco mosaic virus. However, extremely low fermentation production has largely hindered further r...

  • Article
  • Open Access
126 Citations
11,535 Views
14 Pages

11 January 2018

The effects of temperature, agitation and aeration on glycoprotein GP-1 production by Streptomyces kanasenisi ZX01 in bench-scale fermentors were systematically investigated. The maximum final GP-1 production was achieved at an agitation speed of 200...

  • Article
  • Open Access
18 Citations
7,728 Views
16 Pages

Requirements within the Ebola Viral Glycoprotein for Tetherin Antagonism

  • Nathan H. Vande Burgt,
  • Rachel L. Kaletsky and
  • Paul Bates

26 October 2015

Tetherin is an interferon-induced, intrinsic cellular response factor that blocks release of numerous viruses, including Ebola virus, from infected cells. As with many viruses targeted by host factors, Ebola virus employs a tetherin antagonist, the v...

  • Communication
  • Open Access
3 Citations
8,072 Views
10 Pages

22 March 2012

Equine arteritis virus (EAV) is a small, positive-stranded RNA virus. The glycoproteins gp2b, gp3 and gp4 form a heterotrimer in the viral envelope, which is required for cell entry of EAV. We describe expression of the ectodomains of the proteins in...

  • Review
  • Open Access
37 Citations
9,650 Views
11 Pages

31 October 2019

Ebola virus (EBOV) is a highly lethal pathogen that has caused several outbreaks of severe hemorrhagic fever in humans since its emergence in 1976. The EBOV glycoprotein (GP1,2) is the sole viral envelope protein and a major component of immunogenici...

  • Article
  • Open Access
3 Citations
1,837 Views
16 Pages

A Liposome-Based Nanoparticle Vaccine Induces Effective Immunity Against EBV Infection

  • Ping Li,
  • Zihang Yu,
  • Ziyi Jiang,
  • Yike Jiang,
  • Jingjing Shi,
  • Sanyang Han and
  • Lan Ma

28 March 2025

Background: Epstein-Barr virus (EBV) infects approximately 95% of the global population, causing numerous malignancy-related cases annually and some autoimmune diseases. EBV-encoded gp350, gH, gL, gp42 and gB glycoproteins are identified as antigen c...

  • Article
  • Open Access
20 Citations
3,435 Views
11 Pages

Antimicrobial, Anticancer and Multidrug-Resistant Reversing Activity of Novel Oxygen-, Sulfur- and Selenoflavones and Bioisosteric Analogues

  • Małgorzata Anna Marć,
  • Annamária Kincses,
  • Bálint Rácz,
  • Muhammad Jawad Nasim,
  • Muhammad Sarfraz,
  • Carlos Lázaro-Milla,
  • Enrique Domínguez-Álvarez,
  • Claus Jacob,
  • Gabriella Spengler and
  • Pedro Almendros

11 December 2020

Multidrug resistance of cancer cells to cytotoxic drugs still remains a major obstacle to the success of chemotherapy in cancer treatment. The development of new drug candidates which may serve as P-glycoprotein (P-gp) efflux pump inhibitors is a pro...

  • Article
  • Open Access
2 Citations
2,549 Views
15 Pages

30 July 2022

The aim of this study is to follow the gp production in IBDV-vaccinated and challenged birds. The progress of IBDV infection was monitored using anti-VP2 immunocytochemistry, light and transmission electron microscopy. In the medulla of the bursal fo...

  • Article
  • Open Access
5 Citations
3,257 Views
19 Pages

Engineered Human Monoclonal scFv to Receptor Binding Domain of Ebolavirus

  • Jaslan Densumite,
  • Siratcha Phanthong,
  • Watee Seesuay,
  • Nitat Sookrung,
  • Urai Chaisri and
  • Wanpen Chaicumpa

(1) Background: Ebolavirus (EBOV) poses as a significant threat for human health by frequently causing epidemics of the highly contagious Ebola virus disease (EVD). EBOV glycoprotein (GP), as a sole surface glycoprotein, needs to be cleaved in endoso...

  • Article
  • Open Access
24 Citations
6,349 Views
12 Pages

Improvement of Transmembrane Transport Mechanism Study of Imperatorin on P-Glycoprotein-Mediated Drug Transport

  • Zheng-Gen Liao,
  • Tao Tang,
  • Xue-Jing Guan,
  • Wei Dong,
  • Jing Zhang,
  • Guo-Wei Zhao,
  • Ming Yang and
  • Xin-Li Liang

24 November 2016

P-glycoprotein (P-gp) affects the transport of many drugs; including puerarin and vincristine. Our previous study demonstrated that imperatorin increased the intestinal absorption of puerarin and vincristine by inhibiting P-gp-mediated drug efflux. H...

  • Article
  • Open Access
904 Views
22 Pages

LightSpot Fluorescent Conjugates as Highly Efficient Tools for Lysosomal P-gp Quantification in Olaparib-Treated Triple-Negative Breast Cancer Cells

  • Antoine Goisnard,
  • Pierre Daumar,
  • Maxime Dubois,
  • Elodie Gay,
  • Manon Roux,
  • Marie Depresle,
  • Frédérique Penault-Llorca,
  • Emmanuelle Mounetou and
  • Mahchid Bamdad

P-glycoprotein (P-gp) is a key element of cancer treatment resistance, actively extruding cytotoxic drugs from cells and diminishing their efficacy. While its role at the plasma membrane is well established, its intracellular localization, particular...

  • Article
  • Open Access
2 Citations
4,159 Views
8 Pages

Genome-Wide Analysis Reveals the Secondary Metabolome in Streptomyces kanasensis ZX01

  • Guoqiang Zhang,
  • Dailin Yu,
  • Bu Sang,
  • Juntao Feng,
  • Lirong Han and
  • Xing Zhang

30 November 2017

Streptomyces kanasensis ZX01 produces some antibiotics and a glycoprotein with antiviral activity. To further evaluate its biosynthetic potential, here we sequenced the 7,026,279 bp draft genome of S. kanasensis ZX01 and analyzed all identifiable sec...

  • Meeting Report
  • Open Access
6 Citations
4,802 Views
11 Pages

7 November 2018

Recent developments in defining the role of the lentiviral envelope glycoprotein (Env) cytoplasmic tail (CT) in Env trafficking and incorporation into virus particles have advanced our understanding of viral replication and transmission. To stimulate...

  • Article
  • Open Access
2 Citations
2,963 Views
13 Pages

Association between Platelet-Specific Collagen Receptor Glycoprotein 6 Gene Variants, Selected Biomarkers, and Recurrent Pregnancy Loss in Korean Women

  • Hui Jeong An,
  • Eun Hee Ahn,
  • Jung Oh Kim,
  • Chang Soo Ryu,
  • Han Sung Park,
  • Sung Hwan Cho,
  • Ji Hyang Kim,
  • Woo Sik Lee,
  • Jung Ryeol Lee and
  • Young Ran Kim
  • + 1 author

29 July 2020

This paper investigates whether glycoprotein 6 (GP6) gene polymorphisms are a risk factor for recurrent pregnancy loss (RPL) in Korean women. Genotypes were determined by polymerase chain reaction-restriction fragment length polymorphism and real-tim...

  • Article
  • Open Access
1 Citations
4,082 Views
17 Pages

The efflux pump P-glycoprotein (P-gp) affects drug distribution after absorption in humans and animals. P-gp is encoded by the multidrug resistance gene (MDR1) gene in humans, while rodents (the most common preclinical animal model) express the two i...

  • Article
  • Open Access
16 Citations
4,517 Views
18 Pages

Antibody Generation and Immunogenicity Analysis of EBV gp42 N-Terminal Region

  • Junping Hong,
  • Dongmei Wei,
  • Qian Wu,
  • Ling Zhong,
  • Kaiyun Chen,
  • Yang Huang,
  • Wanlin Zhang,
  • Junyu Chen,
  • Ningshao Xia and
  • Xiao Zhang
  • + 1 author

28 November 2021

Epstein–Barr virus (EBV) is the first reported oncogenic virus and infects more than 90% of adults worldwide. EBV can establish a latent infection in B lymphocytes which is essential for persistence and transmission. Glycoprotein gp42 is an ind...

  • Article
  • Open Access
25 Citations
4,360 Views
19 Pages

Phytol and Heptacosane Are Possible Tools to Overcome Multidrug Resistance in an In Vitro Model of Acute Myeloid Leukemia

  • Manuela Labbozzetta,
  • Paola Poma,
  • Marco Tutone,
  • James A. McCubrey,
  • Maurizio Sajeva and
  • Monica Notarbartolo

15 March 2022

Drug resistance is the ability of cancer cells to gain resistance to both conventional and novel chemotherapy agents, and remains a major problem in cancer therapy. Resistance mechanisms are multifactorial and involve more strictly pharmacological fa...

  • Article
  • Open Access
14 Citations
4,339 Views
23 Pages

In Vivo Reversal of P-Glycoprotein-Mediated Drug Resistance in a Breast Cancer Xenograft and in Leukemia Models Using a Novel, Potent, and Nontoxic Epicatechin EC31

  • Wenqin Sun,
  • Iris L. K. Wong,
  • Helen Ka-Wai Law,
  • Xiaochun Su,
  • Terry C. F. Chan,
  • Gege Sun,
  • Xinqing Yang,
  • Xingkai Wang,
  • Tak Hang Chan and
  • Shengbiao Wan
  • + 1 author

22 February 2023

The modulation of P-glycoprotein (P-gp, ABCB1) can reverse multidrug resistance (MDR) and potentiate the efficacy of anticancer drugs. Tea polyphenols, such as epigallocatechin gallate (EGCG), have low P-gp-modulating activity, with an EC50 over 10 &...

  • Article
  • Open Access
6 Citations
3,400 Views
30 Pages

The Role of Elacridar, a P-gp Inhibitor, in the Re-Sensitization of PAC-Resistant Ovarian Cancer Cell Lines to Cytotoxic Drugs in 2D and 3D Cell Culture Models

  • Piotr Stasiak,
  • Justyna Sopel,
  • Julia Maria Lipowicz,
  • Agnieszka Anna Rawłuszko-Wieczorek,
  • Jan Korbecki and
  • Radosław Januchowski

28 January 2025

Chemotherapy resistance is a significant barrier to effective cancer treatment. A key mechanism of resistance at the single-cell level is the overexpression of drug transporters in the ABC family, particularly P-glycoprotein (P-gp), which leads to mu...

  • Article
  • Open Access
10 Citations
3,444 Views
19 Pages

Functional Expression of Multidrug-Resistance (MDR) Transporters in Developing Human Fetal Brain Endothelial Cells

  • Phetcharawan Lye,
  • Enrrico Bloise,
  • Guinever E. Imperio,
  • David Chitayat and
  • Stephen G. Matthews

21 July 2022

There is little information about the functional expression of the multidrug resistance (MDR) transporters P-glycoprotein (P-gp, encoded by ABCB1) and breast cancer resistance protein (BCRP/ABCG2) in the developing blood–brain barrier (BBB). We...

  • Article
  • Open Access
20 Citations
3,907 Views
11 Pages

Reversal Effect of Oxypeucedanin on P-glycoprotein-mediated Drug Transport

  • Wei Dong,
  • Zhen-Gen Liao,
  • Guo-Wei Zhao,
  • Xue-Jing Guan,
  • Jing Zhang,
  • Xin-Li Liang and
  • Ming Yang

P-glycoprotein affects the transport of numerous drugs including chemotherapeutic drugs vincristine sulfate (VCR) and docetaxel (DTX), and is one of the main causes for multidrug resistance. Our previous studies have shown that oxypeucedanin (OPD) ca...

  • Communication
  • Open Access
4 Citations
2,707 Views
8 Pages

Behavioral Evidence for a Tau and HIV-gp120 Interaction

  • Murali Vijayan,
  • Linda Yin,
  • P. Hemachandra Reddy and
  • Khalid Benamar

Despite successful virologic control with combination antiretroviral therapy (cART), about half of people living with the human immunodeficiency virus-1 (HIV) develop an HIV-associated neurocognitive disorder (HAND). It is estimated that 50% of indiv...

  • Article
  • Open Access
22 Citations
3,315 Views
11 Pages

Subtyping Cryptosporidium xiaoi, a Common Pathogen in Sheep and Goats

  • Yingying Fan,
  • Xitong Huang,
  • Sheng Guo,
  • Fang Yang,
  • Xin Yang,
  • Yaqiong Guo,
  • Yaoyu Feng,
  • Lihua Xiao and
  • Na Li

Cryptosporidiosis is a significant cause of diarrhea in sheep and goats. Among the over 40 established species of Cryptosporidium, Cryptosporidium xiaoi is one of the dominant species infecting ovine and caprine animals. The lack of subtyping tools m...

  • Article
  • Open Access
7 Citations
3,064 Views
16 Pages

Conformational Stabilization of Gp41-Mimetic Miniproteins Opens Up New Ways of Inhibiting HIV-1 Fusion

  • Mario Cano-Muñoz,
  • Julie Lucas,
  • Li-Yun Lin,
  • Samuele Cesaro,
  • Christiane Moog and
  • Francisco Conejero-Lara

Inhibition of the HIV-1 fusion process constitutes a promising strategy to neutralize the virus at an early stage before it enters the cell. In this process, the envelope glycoprotein (Env) plays a central role by promoting membrane fusion. We previo...

  • Article
  • Open Access
304 Views
27 Pages

Elacridar Reverses P-gp-Mediated Drug Resistance in Ovarian Cancer Cells in 2D and 3D Culture Models

  • Piotr Stasiak,
  • Justyna Sopel,
  • Julia Maria Lipowicz,
  • Agnieszka Anna Rawłuszko-Wieczorek,
  • Karolina Sterzyńska,
  • Jan Korbecki and
  • Radosław Januchowski

16 December 2025

Multidrug resistance (MDR) remains a major obstacle in the treatment of ovarian cancer. MDR is often mediated by the overexpression of ATP-binding cassette (ABC) transporters, such as P-glycoprotein (P-gp) and Breast Cancer Resistance Protein (BCRP)....

  • Article
  • Open Access
2 Citations
2,282 Views
18 Pages

DNA Vaccines Encoding HTNV GP-Derived Th Epitopes Benefited from a LAMP-Targeting Strategy and Established Cellular Immunoprotection

  • Dongbo Jiang,
  • Junqi Zhang,
  • Wenyang Shen,
  • Yubo Sun,
  • Zhenjie Wang,
  • Jiawei Wang,
  • Jinpeng Zhang,
  • Guanwen Zhang,
  • Gefei Zhang and
  • Yueyue Wang
  • + 14 authors

19 August 2024

Vaccines has long been the focus of antiviral immunotherapy research. Viral epitopes are thought to be useful biomarkers for immunotherapy (both antibody-based and cellular). In this study, we designed a novel vaccine molecule, the Hantaan virus (HTN...

  • Article
  • Open Access
5 Citations
4,177 Views
19 Pages

Immunization with GP1 but Not Core-like Particles Displaying Isolated Receptor-Binding Epitopes Elicits Virus-Neutralizing Antibodies against Junín Virus

  • Gleyder Roman-Sosa,
  • Anne Leske,
  • Xenia Ficht,
  • Tung Huy Dau,
  • Julia Holzerland,
  • Thomas Hoenen,
  • Martin Beer,
  • Robert Kammerer,
  • Reinhold Schirmbeck and
  • Felix A. Rey
  • + 2 authors

22 January 2022

New World arenaviruses are rodent-transmitted viruses and include a number of pathogens that are responsible for causing severe human disease. This includes Junín virus (JUNV), which is the causative agent of Argentine hemorrhagic fever. The w...

  • Article
  • Open Access
18 Citations
3,227 Views
18 Pages

Protection against Marburg Virus and Sudan Virus in NHP by an Adenovector-Based Trivalent Vaccine Regimen Is Correlated to Humoral Immune Response Levels

  • Machteld M. Tiemessen,
  • Laura Solforosi,
  • Liesbeth Dekking,
  • Dominika Czapska-Casey,
  • Jan Serroyen,
  • Nancy J. Sullivan,
  • Ariane Volkmann,
  • Maria Grazia Pau,
  • Benoit Callendret and
  • Hanneke Schuitemaker
  • + 3 authors

5 August 2022

The Marburg virus (MARV) and Sudan virus (SUDV) belong to the filovirus family. The sporadic human outbreaks occur mostly in Africa and are characterized by an aggressive disease course with high mortality. The first case of Marburg virus disease in...

  • Article
  • Open Access
7 Citations
3,790 Views
17 Pages

Development of a Multivalent Kunjin Virus Reporter Virus-Like Particle System Inducing Seroconversion for Ebola and West Nile Virus Proteins in Mice

  • Pham-Tue-Hung Tran,
  • Naveed Asghar,
  • Urban Höglund,
  • Olivia Larsson,
  • Lars Haag,
  • Ali Mirazimi,
  • Magnus Johansson and
  • Wessam Melik

Kunjin virus (KUNV) is an attenuated strain of the severe neurotropic West Nile virus (WNV). The virus has a single-strand positive-sense RNA genome that encodes a polyprotein. Following gene expression, the polyprotein is cleaved into structural pro...

  • Article
  • Open Access
8 Citations
3,223 Views
20 Pages

In Silico Analyses, Experimental Verification and Application in DNA Vaccines of Ebolavirus GP-Derived pan-MHC-II-Restricted Epitopes

  • Junqi Zhang,
  • Baozeng Sun,
  • Wenyang Shen,
  • Zhenjie Wang,
  • Yang Liu,
  • Yubo Sun,
  • Jiaxing Zhang,
  • Ruibo Liu,
  • Yongkai Wang and
  • Tianyuan Bai
  • + 8 authors

20 October 2023

(1) Background and Purpose: Ebola virus (EBOV) is the causative agent of Ebola virus disease (EVD), which causes extremely high mortality and widespread epidemics. The only glycoprotein (GP) on the surface of EBOV particles is the key to mediating vi...

  • Article
  • Open Access
11 Citations
4,902 Views
14 Pages

Effect of Rumex Acetosa Extract, a Herbal Drug, on the Absorption of Fexofenadine

  • Jung Hwan Ahn,
  • Junhyeong Kim,
  • Naveed Ur Rehman,
  • Hye-Jin Kim,
  • Mi-Jeong Ahn and
  • Hye Jin Chung

Herbal drugs are widely used for the auxiliary treatment of diseases. The pharmacokinetics of a drug may be altered when it is coadministered with herbal drugs that can affect drug absorption. The effects of herbal drugs on absorption must be evaluat...

  • Feature Paper
  • Review
  • Open Access
15 Citations
12,357 Views
23 Pages

Drug–Drug Interactions Involving Dexamethasone in Clinical Practice: Myth or Reality?

  • Venceslas Bourdin,
  • William Bigot,
  • Anthony Vanjak,
  • Ruxandra Burlacu,
  • Amanda Lopes,
  • Karine Champion,
  • Audrey Depond,
  • Blanca Amador-Borrero,
  • Damien Sene and
  • Chloe Comarmond
  • + 1 author

15 November 2023

Concomitant administration of multiple drugs frequently causes severe pharmacokinetic or pharmacodynamic drug–drug interactions (DDIs) resulting in the possibility of enhanced toxicity and/or treatment failure. The activity of cytochrome P450 (...

  • Article
  • Open Access
3 Citations
2,139 Views
17 Pages

A BPTF Inhibitor That Interferes with the Multidrug Resistance Pump to Sensitize Murine Triple-Negative Breast Cancer Cells to Chemotherapy

  • Melanie M. Sinanian,
  • Afshan Rahman,
  • Ahmed M. Elshazly,
  • Victoria Neely,
  • Balaji Nagarajan,
  • Glen E. Kellogg,
  • April L. Risinger and
  • David A. Gewirtz

22 October 2024

Triple-negative breast cancer (TNBC) is associated with a generally poor prognosis due to its highly aggressive and metastatic nature, lack of targetable receptors, as well as the frequent development of resistance to chemotherapy. We previously repo...

  • Review
  • Open Access
9 Citations
5,406 Views
15 Pages

29 June 2023

Type 2 diabetes mellitus (T2DM) is a persistent metabolic condition that contributes to the development of cardiovascular diseases. Numerous studies have provided evidence that individuals with T2DM are at a greater risk of developing cardiovascular...

  • Review
  • Open Access
17 Citations
11,209 Views
21 Pages

13 March 2024

In CNS drug discovery, the estimation of brain exposure to lead compounds is critical for their optimization. Compounds need to cross the blood–brain barrier (BBB) to reach the pharmacological targets in the CNS. The BBB is a complex system inv...

  • Article
  • Open Access
19 Citations
6,122 Views
14 Pages

4 February 2016

Multidrug resistance (MDR) is a prime reason for numerous failed oncotherapy approaches. In the present study, we investigated whether Alisol F 24 acetate (ALI) could reverse the MDR of MCF-7/DOX cells, a multidrug-resistant human breast cancer cell...

  • Article
  • Open Access
6 Citations
7,415 Views
17 Pages

14 October 2016

BST-2 or tetherin is a host cell restriction factor that prevents the budding of enveloped viruses at the cell surface, thus impairing the viral spread. Several countermeasures to evade this antiviral factor have been positively selected in retroviru...

  • Review
  • Open Access
35 Citations
8,786 Views
24 Pages

GP130 Cytokines in Breast Cancer and Bone

  • Tolu Omokehinde and
  • Rachelle W. Johnson

31 January 2020

Breast cancer cells have a high predilection for skeletal homing, where they may either induce osteolytic bone destruction or enter a latency period in which they remain quiescent. Breast cancer cells produce and encounter autocrine and paracrine cyt...

  • Article
  • Open Access
1 Citations
1,498 Views
24 Pages

Anticancer Activity of Paclitaxel-Loaded Mesoporous Silica Nanoparticles in B16F10 Melanoma-Bearing Mice

  • Jihoon Lee,
  • Jung Mo Kim,
  • Yeon-Ju Baek,
  • Hyojeung Kang,
  • Min-Koo Choi and
  • Im-Sook Song

Background/Objectives: Paclitaxel (PTX) faces clinical limitations in melanoma treatment due to poor solubility, P-glycoprotein (P-gp)-mediated efflux, and systemic toxicity. This study aimed to develop PTX-loaded mesoporous silica nanoparticles (PS)...

  • Article
  • Open Access
7 Citations
6,638 Views
11 Pages

Role of 14-3-3ζ in Platelet Glycoprotein Ibα-von Willebrand Factor Interaction-Induced Signaling

  • Weilin Zhang,
  • Lili Zhao,
  • Jun Liu,
  • Juan Du,
  • Rong Yan and
  • Kesheng Dai

2 May 2012

The interaction of platelet glycoprotein (GP) Ib-IX with von Willebrand factor (VWF) exposed at the injured vessel wall or atherosclerotic plaque rupture initiates platelet transient adhesion to the injured vessel wall, which triggers intracellular s...

  • Article
  • Open Access
6 Citations
4,587 Views
23 Pages

Structurally Different Yet Functionally Similar: Aptamers Specific for the Ebola Virus Soluble Glycoprotein and GP1,2 and Their Application in Electrochemical Sensing

  • Soma Banerjee,
  • Mahsa Askary Hemmat,
  • Shambhavi Shubham,
  • Agnivo Gosai,
  • Sivaranjani Devarakonda,
  • Nianyu Jiang,
  • Charith Geekiyanage,
  • Jacob A. Dillard,
  • Wendy Maury and
  • Pranav Shrotriya
  • + 2 authors

27 February 2023

The Ebola virus glycoprotein (GP) gene templates several mRNAs that produce either the virion-associated transmembrane protein or one of two secreted glycoproteins. Soluble glycoprotein (sGP) is the predominant product. GP1 and sGP share an amino ter...

  • Article
  • Open Access
2 Citations
2,929 Views
19 Pages

Computational Modulation of the V3 Region of Glycoprotein gp125 of HIV-2

  • Patrícia A. Serra,
  • Nuno Taveira and
  • Rita C. Guedes

16 February 2021

HIV-2 infection is frequently neglected in HIV/AIDS campaigns. However, a special emphasis must be given to HIV-2 as an untreated infection that also leads to AIDS and death, and for which the efficacy of most available drugs is limited against HIV-2...

  • Feature Paper
  • Article
  • Open Access
38 Citations
4,744 Views
26 Pages

Dual P-Glycoprotein and CA XII Inhibitors: A New Strategy to Reverse the P-gp Mediated Multidrug Resistance (MDR) in Cancer Cells

  • Elisabetta Teodori,
  • Laura Braconi,
  • Silvia Bua,
  • Andrea Lapucci,
  • Gianluca Bartolucci,
  • Dina Manetti,
  • Maria Novella Romanelli,
  • Silvia Dei,
  • Claudiu T. Supuran and
  • Marcella Coronnello

10 April 2020

A new series of N,N-bis(alkanol)amine aryl diesters was synthesized and studied as dual P-glycoprotein (P-gp) and carbonic anhydrase XII inhibitors (CA XII). These hybrids should be able to synergistically overcome P-gp mediated multidrug resistance...

  • Article
  • Open Access
11 Citations
6,504 Views
20 Pages

7 June 2012

P-glycoprotein (P-gp) is an efflux pump involved in the protection of tissues of several organs by influencing xenobiotic disposition. P-gp plays a key role in multidrug resistance and in the progression of many neurodegenerative diseases. The develo...

  • Article
  • Open Access
9 Citations
5,068 Views
12 Pages

Efficient Expression and Processing of Ebola Virus Glycoprotein Induces Morphological Changes in BmN Cells but Cannot Rescue Deficiency of Bombyx Mori Nucleopolyhedrovirus GP64

  • Jinshan Huang,
  • Na Liu,
  • Fanbo Xu,
  • Ellen Ayepa,
  • Charles Amanze,
  • Luping Sun,
  • Yaqin Shen,
  • Miao Yang,
  • Shuwen Yang and
  • Xingjia Shen
  • + 1 author

15 November 2019

Ebola virus (EBOV) disease outbreaks have resulted in many fatalities, yet no licensed vaccines are available to prevent infection. Recombinant glycoprotein (GP) production may contribute to finding a cure for Ebola virus disease, which is the key ca...

  • Article
  • Open Access
6 Citations
4,764 Views
29 Pages

A Prime-Boost Immunization Strategy with Vaccinia Virus Expressing Novel gp120 Envelope Glycoprotein from a CRF02_AG Isolate Elicits Cross-Clade Tier 2 HIV-1 Neutralizing Antibodies

  • Rita Calado,
  • Joana Duarte,
  • Pedro Borrego,
  • José Maria Marcelino,
  • Inês Bártolo,
  • Francisco Martin,
  • Inês Figueiredo,
  • Silvia Almeida,
  • Luís Graça and
  • Jorge Vítor
  • + 4 authors

Development of new immunogens eliciting broadly neutralizing antibodies (bNAbs) is a main priority for the HIV-1 vaccine field. Envelope glycoproteins from non-B-non-C HIV-1clades have not been fully explored as components of a vaccine. We produced V...

  • Article
  • Open Access
1 Citations
968 Views
17 Pages

26 February 2025

The tropism of the Human Immunodeficiency Virus type 1 (HIV-1) is determined by the use of either or both chemokine coreceptors CCR5 (R5) and CXCR4 (X4) for entry into the target cell. The ability of HIV-1 to bind R5 or X4 is determined primarily by...

  • Article
  • Open Access
8 Citations
4,204 Views
19 Pages

LightSpot®-FL-1 Fluorescent Probe: An Innovative Tool for Cancer Drug Resistance Analysis by Direct Detection and Quantification of the P-glycoprotein (P-gp) on Monolayer Culture and Spheroid Triple Negative Breast Cancer Models

  • Antoine Goisnard,
  • Pierre Daumar,
  • Clémence Dubois,
  • Corinne Aubel,
  • Manon Roux,
  • Marie Depresle,
  • Jean Gauthier,
  • Bernard Vidalinc,
  • Frédérique Penault-Llorca and
  • Emmanuelle Mounetou
  • + 1 author

11 August 2021

P-gp is the most widely studied MDR protein conferring cellular resistance to many standard or targeted therapeutic agents. For this reason, P-gp chemoresistance evaluation, established before or during chemotherapy, can be very relevant in order to...

  • Article
  • Open Access
3 Citations
2,141 Views
14 Pages

Single Exposure to Low-Intensity Focused Ultrasound Causes Biphasic Opening of the Blood-Brain Barrier Through Secondary Mechanisms

  • Tasneem A. Arsiwala,
  • Kathryn E. Blethen,
  • Cullen P. Wolford,
  • Geoffrey L. Pecar,
  • Dhruvi M. Panchal,
  • Brooke N. Kielkowski,
  • Peng Wang,
  • Manish Ranjan,
  • Jeffrey S. Carpenter and
  • Victor Finomore
  • + 2 authors

Background/Objective: The blood–brain barrier (BBB) is selectively permeable, but it also poses significant challenges for treating CNS diseases. Low-intensity focused ultrasound (LiFUS), paired with microbubbles is a promising, non-invasive te...

of 14